To evaluate the safety and efficacy of therapy with etanercept and methotrexate (MTX) in patients with active rheumatoid arthritis (RA) and mild hepatitis C virus (HCV) infection.

Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial

Gremese, Elisa;
2014-01-01

Abstract

To evaluate the safety and efficacy of therapy with etanercept and methotrexate (MTX) in patients with active rheumatoid arthritis (RA) and mild hepatitis C virus (HCV) infection.
2014
DISEASE ACTIVITY SCORE
GISEA
HEALTH ASSESSMENT QUESTIONNAIRE
TNF-α INHIBITORS
TRANSAMINASES
Adult
Aged
Alanine Transaminase
Antirheumatic Agents
Arthritis
Rheumatoid
Aspartate Aminotransferases
Drug Therapy
Combination
Female
Hepacivirus
Hepatitis C
Humans
Immunoglobulin G
Liver Function Tests
Male
Methotrexate
Middle Aged
Prospective Studies
Receptors
Tumor Necrosis Factor
Severity of Illness Index
Treatment Outcome
Viral Load
Virus Replication
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/85620
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 43
  • ???jsp.display-item.citation.isi??? 42
social impact